Today: 11 June 2026
Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next
11 January 2026
2 mins read

Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next

NEW YORK, Jan 11, 2026, 09:49 EST — Market closed

  • Shares of Tri Pointe Homes jumped 8.7% at Friday’s close, beating the gains of most U.S. homebuilders.
  • The surge came after the White House announced a $200 billion purchase of mortgage bonds, designed to drive rates lower.
  • Tuesday’s U.S. CPI report is the next hurdle for traders, with builders’ earnings season looming just after.

Shares of Tri Pointe Homes jumped 8.7% to close Friday at $35.42, lifted by a broad rally in housing-related stocks. The move came amid speculation that a federal program to purchase mortgage-backed securities might ease borrowing costs.

The move is significant because homebuilder demand is more sensitive to monthly payments than to headline home prices. President Donald Trump announced the administration would order a $200 billion purchase of mortgage bonds, with Federal Housing Finance Agency Director Bill Pulte confirming Fannie Mae and Freddie Mac would carry it out. TD Cowen noted this buying might tighten the spread between the 30-year mortgage and the 10-year Treasury yield, potentially lowering mortgage rates. Still, Brian Jacobsen from Annex Wealth Management cautioned that while the plan could boost demand, it doesn’t address the supply side.

For Tri Pointe, investors are caught in a push-pull: lower mortgage rates might lure buyers back, yet rising demand could hold prices firm, curbing the gains in affordability.

Policy news lifted other builders on Friday, with bigger names like Lennar, D.R. Horton, and PulteGroup also gaining. Investors bet mortgage rates might slide back into a range that sparks volume again.

RBC Capital’s Mike Dahl wasn’t buying into the surge. He lowered Tri Pointe’s price target from $37 to $31 and kept a “Sector Perform” rating. Dahl flagged caution through early 2026, citing ongoing affordability issues. He did note a potential boost from repair-and-remodel activity later in the year. (A price target is an analyst’s estimate of where the stock could trade over the next 12 months.) TipRanks

The distance between Friday’s close and RBC’s target highlights just how quickly macro headlines shifted the tape, rather than any new company data. Tri Pointe hasn’t released earnings or guidance in the past two days.

The next big macro event is just around the corner. The Bureau of Labor Statistics will drop December’s CPI figures Tuesday, Jan. 13, at 8:30 a.m. ET. This release has the power to move Treasury yields—and with them, mortgage-rate forecasts.

Investors will sift through a busy U.S. data slate this week, with retail sales and producer prices in focus for hints on interest rate moves. Homebuilders have been trading on expectations shaped by the affordability crunch expected in 2025.

The downside is clear: if the mortgage-bond plan stalls during rollout, or investors push for higher yields regardless, mortgage rates might barely budge. Builder stocks could then lose their policy-driven gains just as fast.

As Monday’s session kicks off, traders will be eyeing if Tri Pointe’s recent move sticks in early trading. They’ll also keep tabs on whether the sector continues to follow rate-sensitive cues, such as the 10-year Treasury yield.

After Tuesday’s inflation data, the focus shifts to earnings season. Tri Pointe is set to release its next quarterly report roughly on Feb. 17, per Zacks.

Stock Market Today

  • Ideaya Biosciences Stock Drops 10% Amid $300M Fundraising Despite Bullish Outlook
    June 10, 2026, 10:30 PM EDT. Shares of Ideaya Biosciences ($IDYA) fell 10% to around $27 following the announcement of a $300 million stock offering priced at $27 per share, diluting existing shareholder value. The biotech firm had surged 13% earlier due to promising oncology trial results presented at ASCO. Analysts from Citizens reaffirmed a Market Outperform rating and a $45 target, citing robust pipeline developments and collaborations, including a deal with Roche on a novel oncology drug combination. Positive clinical data showed a 37% response rate in uveal melanoma, substantially outperforming standard care. The cash raise aims to advance multiple cancer trials, ensuring a solid financial runway despite near-term stock pressure from dilution.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split
Previous Story

Bloom Energy stock heads into Monday after $2.65 billion AEP fuel-cell order sparks fresh analyst split

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape
Next Story

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Go toTop